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Abstract: The objective of this pilot study was to investigate the use of and satisfaction with 
a chronic obstructive pulmonary disease (COPD) telehealth program applied in both primary 
and secondary care. The program consisted of four modules: 1) activity coach for ambulant 
activity monitoring and real-time coaching of daily activity behavior, 2) web-based exercise 
program for home exercising, 3) self-management of COPD exacerbations via a triage diary on 
the web portal, including self-treatment of exacerbations, and 4) teleconsultation. Twenty-nine 
COPD patients were randomly assigned to either the intervention group (telehealth program 
for 9 months) or the control group (usual care). Page hits on the web portal showed the use of 
the program, and the Client Satisfaction Questionnaire showed satisfaction with received care. 
The telehealth program with decision support showed good satisfaction (mean 26.4, maximum 
score 32). The program was accessed on 86% of the treatment days, especially the diary. Patient 
adherence with the exercise scheme was low (21%). Health care providers seem to play an 
important role in patients’ adherence to telehealth in usual care. Future research should focus 
on full-scale implementation in daily care and investigating technological advances, like gam-
ing, to increase adherence.
Keywords: COPD, physical activity, exacerbations, telehealth, self-management
Introduction
Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow 
limitation of the airways, and has a large effect on physical, psychological, and social 
functioning.1,2 In patients with COPD, dyspnea (during exertion) is one of the major 
symptoms, which leads to an inactive lifestyle. As inactivity is associated with poor 
prognosis, several (inter)national guidelines advise promoting physical activity in daily 
life.3,4 In addition exacerbations have a serious negative impact on patients’ quality of life 
and result in prolonged activity limitation.5,6
The optimal management of COPD is complex, due to a heterogeneous picture 
of progressive deterioration, as well as the great variation in symptoms, functional 
limitations, and well-being that patients with COPD experience.5,7,8 Multidisciplinary 
integrated programs have been shown to be able to optimize quality of life and exercise 
tolerance,9 especially when containing an exercise program.10 However, these programs 
are advised to be more individually tailored and accessible by the patient when they 
need it most.11,12 Recent technological advances in health care could supply this need 
by telemonitoring of activity and symptoms, and provide treatment in daily life.
For example, Nguyen et al incorporated technology in their dyspnea self-
 management program, to support early recognition of worsening symptoms through 
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real-time monitoring, quick feedback, and access to 
information and support.13 In a study by Jensen et al, a 
telehealth monitor collected and transmitted data about the 
patient to a web-based portal or electronic health care record, 
while professionals could monitor progress and training 
inputs and provide advice to the patient.14 Active involve-
ment of a case manager is needed for final interpretation of 
monitoring data or feedback to the patient, which might slow 
the care process. We would assume that by using decision-
support technology and automated feedback to the patient, 
telehealth interventions can contribute to more effective and 
efficient quality health care.
The potential of telehealth regarding health care utiliza-
tion and costs, acceptability, or clinical characteristics is the 
starting point for development of interventions. However, 
reviews show that the overall benefits are not yet proven,15,16 
and limited evidence has been reported for their value in 
chronic disease management.17 Multimodal telehealth pro-
grams that monitor patient behavior and symptoms in daily 
life to deliver intensive personal automated feedback to 
improve activity behavior, facilitate home exercising, and 
empower patients in self-care and disease management have 
not been investigated at all.
In this paper, we describe a technology-supported care 
program that supports the treatment of COPD patients 
through self-treatment of exacerbations, and promotion of an 
active lifestyle by real-time coaching and home exercising via 
a web portal. This program was applied as blended care, ie, 
implemented within usual care – primary and secondary – to 
explore the potential for daily health care practice. The care 
was individualized by health care professionals based on 
the patient characteristics and progress of every individual 
patient in order to resemble future telemedicine use in daily 
practice as much as possible. Understanding the use of and 
adherence with such an intervention is essential for future 
telemedicine interventions.18 Therefore, we performed a 
pilot study to investigate the use of a telehealth program in 
detail and explore the satisfaction experienced with received 
care. As this pilot study was run as a miniature randomized 
controlled trial, we also explored the clinical measures of 
the telehealth program compared to usual care in terms of 
hospitalizations, health status, exercise capacity, symptoms, 
activity level, and quality of life.
Materials and methods
In this pilot study, we performed a miniature randomized 
controlled trial. Patients were eligible for inclusion if they 
fulfilled the COPE II (Study of the effects of self-treatment 
and an exercise program within a self-management program 
in outpatients with COPD) study criteria, as described pre-
viously.19 These include, eg, no exacerbation in the month 
prior to enrollment and three or more exacerbations or 
one hospitalization for respiratory problems in the 2 years 
preceding study entry. Besides these COPE II criteria, 
patients should also have a computer with Internet access 
at home. The study took place in the Medisch Spectrum 
Twente Hospital and primary care physiotherapy practices 
in Enschede, the Netherlands, between December 2011 
and July 2013. Patients started study participation in April, 
July, or September 2012, and the duration of the study was 
9 months. The study was approved by the Twente Medical 
Ethical Committee and registered in The Netherlands Trial 
Register (NTR3072).
Sample size was based upon the estimated number of 
patients that could be included within the recruitment period 
and the availability of technology. Patients were randomized 
using a computer-generated randomization list (Blocked 
Stratified Randomization version 5; Steven Piantadosi), 
where randomization was applied in random blocks of two 
and four. Participants were allocated by a data manager in 
order of inclusion following the randomization list, placed 
in a sealed envelope.
Intervention group: telehealth program
The framework for the technology-supported care program, 
called the Condition Coach, was provided by previous work 
on self-management programs,19 home-exercise programs,20 
changing activity behavior,21,22 and telemedicine interven-
tions.22,23 The Condition Coach consists of four modules 
(Figure 1):
Teleconsultation Web-based exercising
Self-management Activity coach
Figure 1 The telehealth-program modules.
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1. A web-based exercise program on the web portal, 
originating from the COPE II and Pulmofit (Study of 
the effect of immediate reactivation on length of stay in 
the hospital in patients with an exacerbation of COPD) 
studies.20,24 This included breathing exercises, relaxation, 
mobilization, resistance and endurance training, and 
mucus clearance. For every individual patient, exercise 
schemes were created by the patient’s physiotherapist 
via the web portal. A scheme represents which exercises 
should be performed by the patient for which day, and 
which part of the day. Every exercise consists of a text 
description and movie. The patient is able to log in at 
home, follow the exercise scheme, execute the exercises, 
and provide feedback to the physiotherapist. Apart from 
the exercise scheme, patients can perform an extra 
exercise with the “additional exercises” option. Before 
the start of the program, patients received instructions 
from the primary care physiotherapist explaining the web 
portal and for performing baseline measures. There was 
no standardized exercise protocol: the physiotherapist 
could freely select the exercises for each patient for the 
online exercise program. This exercise program could 
be adapted during the intervention period following the 
progress of the patient at the discretion of the therapist. 
Both primary and secondary care professionals could 
supervise the patient at a distance by checking progress 
on the web portal.
2. Activity coach for ambulant activity registration and real-
time feedback to improve daily activity. The activity coach 
consists of an accelerometer-based activity sensor (Inertia 
Technology, Enschede, the Netherlands) and a smartphone 
(Desire S; HTC, New Taipei, Taiwan). The smartphone 
shows the measured activity cumulatively in a graph, 
together with the cumulative activity the users should 
aim for: the reference activity line. In addition, the users 
received motivational cues during the day for awareness 
and extra motivation. These messages were based on the 
activity of the last 2 hours and of the day so far. Each cue 
provided a summary of the activity behavior and advice on 
how to continue the activity behavior, eg, “You have been 
very active today, but took some rest now. Keep on going 
like this, and keep in mind your activity balance.” At the 
end of the day, the patient received a summary of their 
activity behavior (eg, “You were clearly less active today. 
Discuss this with your physiotherapist”). The participant’s 
measured activity levels were also displayed on the web 
portal. The physiotherapist determined for each individual 
patient how and when the activity-coach module was used. 
Likewise, the reference activity line could be completed 
on the web portal, without restrictions, although the 
physiotherapist could use activity-monitoring data of the 
patient as a starting point.
3. A self-management module on the web portal that 
enables patients to treat exacerbations themselves, 
without the intervention of a health care professional. 
This self-treatment protocol has been described in detail 
previously.19 Every day, participants were asked to fill in 
the diary on the web portal, which is the digital version 
of the diary used by Effing et al.19 The decision tree of 
this diary was translated into a decision-support system 
that automatically formed advice to start medication 
in cases of worsening of the clinical condition. Before 
the start of the program, participants had to attend two 
90-minute self-management teaching sessions given by 
a nurse practitioner, to learn how to complete the daily 
diary.19 Patients were also educated in early recognition 
of exacerbations and in starting standardized treatment in 
the case of an exacerbation. After successful completion 
of the teaching sessions, patients received recipes for their 
medication. In the case of an exacerbation, a standardized 
intervention was initiated: prednisolone 30 mg for 7 days, 
and when indicated in combination with antibiotics 
(amoxicillin/clavulanic acid  [Augmentin® 500/125 mg; 
GlaxoSmithKline, Brentford, UK]) three times daily for 
a period of 7 days or (in the case of hypersensitivity) 
doxycycline 100 mg for a period of 10 days.19 Patients 
were instructed to call the study office if they desired 
assistance, and if needed, a consultation with a chest phy-
sician or nurse practitioner was scheduled accordingly. 
These health care professionals could access the diary 
data via the web portal.
4. Teleconsultation module for comments and asking ques-
tions of the patient’s primary care physiotherapist and 
vice versa, via the web portal. These include both general 
and specific comments/questions concerning certain 
exercises in the patient’s exercise scheme.
Control group: usual care
Participants in the control group received only usual care. 
This meant that in the case of an impending exacerba-
tion, the participants had to contact their medical doctor 
as usual. This could be either the general practitioner or 
chest physician, or in some cases the emergency room 
 department. Patients in the control group were allowed to 
attend regular physiotherapy sessions if this was prescribed 
as part of usual care.
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Outcome measures
In both the intervention and control groups, questionnaires 
were administered at T0 (inclusion), T1 (1 month), T2 
(3 months), T3 (6 months), and T4 (9 months). For the inter-
vention group, use of the application was registered by the 
system between the T0 measurement and the T4 measurement. 
Use of the application was calculated for all patients, includ-
ing patients that did not complete the study participation. 
Adherence to the online diary was calculated by dividing the 
number of diary fill-outs by the number of treatment days. 
Adherence to the exercise scheme was calculated by dividing 
the number of schemes that were prescribed by the number of 
schemes performed. In both groups, satisfaction with received 
care was measured by the Client Satisfaction Questionnaire 8. 
The total score range is 8–32, and a higher score indicates a 
higher degree of client satisfaction.
Regarding the clinical outcome measures, the number of 
hospitalizations, length of stay, and emergency department 
visits were registered during the 9-month follow-up period 
in both groups. The decision-support diary automatically 
identified exacerbations following previously described 
criteria19 for the intervention group, while the control group 
filled in a paper version of the diary. The activity sensor 
of the activity coach was used for registration of activity 
levels in both groups, expressed in the time integral of the 
modulus of accelerometer output (IMA; counts per minute).25 
A measurement day should have consisted of 6 or more hours. 
The Baecke Physical Activity Questionnaire was used for 
assessing self-perceived activity levels. Additional outcome 
measures to evaluate the clinical changes were: exercise 
tolerance (6-minute walk test [6MWT]), fatigue (Multidimen-
sional Fatigue  Inventory 20), health status (Clinical COPD 
 Questionnaire), dyspnea  (Medical Research Council scale, as 
defined in the Dutch physiotherapy guidelines3) and quality of 
life  (EuroQol-5D). Questionnaires were administered in both 
groups from T0 to T4; 6MWT was not performed at T1.
statistical methods
A standard package was used (SPSS 19.0; IBM, Armonk, 
NY, USA). For baseline demographics, differences between 
the groups were analyzed using the independent t-test (in the 
case of normal distribution) or Wilcoxon’s rank-sum test. For 
comparing two categorical variables, Pearson’s χ2 or Fisher’s 
exact test was used. Alpha was set at 0.05.
To present the outcome measures over time in both 
groups, a mixed-model analysis for repeated measures was 
performed (intention to treat). Time of measurement (T0–T2) 
was used as a within-subjects factor and group (telehealth 
or usual care) as a between-subjects factor. The clinical 
 outcomes were presented as means and standard error. As this 
was a miniature randomized controlled trial without power 
analysis, no statistical tests were performed.
Results
Although 101 patients fulfilled the COPE II study criteria, 
only 29 patients (29%) were able and willing to participate. 
101 eligible patients
29 patients underwent randomization
Intervention n=15
T0 n=12
T1 n=11
T2 n=11
T3 n=10
T4 n=10
Control n=14
T0 n=12
T1 n=9
T2 n=9
T3 n=4
T4 n=2
Personal problems (n=1),
wanted intervention (n=1)
Too much effort (n=2),
exacerbation (n=1) 
Hospitalization (n=2),
rehabilitation program
(n=1), kidney problems
(n=1), technical issues (n=1)
Exacerbation and cancer (n=1),
rehabilitation program
(n=1) 
Personal loss (n=1),
lobectomy (n=1), no change
therapist (n=1) 
Personal worries (n=1)
Too many exacerbations
(n=1)
72 patients not able/
willing to participate
Figure 2 Flowchart for recruitment, randomization, and dropout.
Abbreviations: T0, inclusion; T1, 1 month; T2, 3 months; T3, 6 months; T4, 9 months.
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The reason for not participating was that patients did not 
fulfill the additional criterion of having a computer with 
Internet access at home. Figure 2 shows the progression of 
the participants through the study. A large number of patients 
were not able or willing to continue study participation: 
33% in the intervention group and 86% in the control group. 
Although some patients in the intervention group quit the 
physiotherapy modules (exercising and activity coach) due 
to weak (n=1, ,T1) or unstable condition (n=1, ,T2) and 
personal circumstances (n=2, ,T4), they persisted in using 
the web portal and triage diary till T4. Table 1 shows the 
baseline characteristics for both the intervention and control 
groups. There was a significant difference found for baseline 
dyspnea levels between groups (P=0.03), showing better 
clinical measures in the telehealth group.
Use and satisfaction
Figure 3 shows the percentage of treatment days that patients 
visited the web portal per intervention month. The web por-
tal was highly used over time, and no large changes were 
observed between months (Figure 3).
Table 2 shows in more detail the specific use of the web 
portal per patient. In a number of patients, the intervention 
period (T0–T4) lasted more than 9 months. The web portal 
was used in 86.4% of days during the intervention, in which 
the triage diary was the mostly used module (median 82.8%). 
In total, 569 exercise schemes were prescribed to the patients, 
of which 127 schemes were completely performed (median 
adherence 21.0%). A total of 1,110 exercises were prescribed 
to the patients within the exercise schemes.  Additionally, 
543 exercises were performed independently (additional 
exercises option). Patients 5, 9, 10, and 12 stopped using 
the exercise and activity modules, but continued using the 
diary.
In the intervention group, the activity coach-module was 
used for 299 days in total, of which 132 days were in the moni-
toring mode and 167 days in the feedback mode. Although 
both monitoring and feedback modes were used, the activity 
coach was rarely used outside of the measurement weeks 
(T0–T4). The use of the web portal differed greatly between 
patients; some used the diary almost every day, other only 
half of the days. Some performed regular additional exercises, 
while others did not use the exercise module at all.
Figure 4 shows the number of patients who received 
exercise schemes from their physiotherapist over time. 
Eight of 12 patients received an exercise scheme from the 
therapist, and the number of prescribed schedules declined 
over time. The average number of schemes prescribed by the 
physiotherapists to individual patients tended to increase in 
the first half-year. In the first month, only one patient received 
an exercise scheme.
Satisfaction with received care (maximum score 32), as 
obtained by repeated measures (mean [standard error]) was 
26.4 (1.3) for the telehealth group and 30.4 (1.5) for the usual-
care group at T1. At T2, this was 26.3 (1.3) for the telehealth 
group and 29.9 (1.4) for the usual-care group.
Clinical measures
Table 3 describes the number and duration of hospitaliza-
tions, emergency room visits, and number of exacerbations 
Table 1 Baseline demographics and clinical characteristics
Variable n Telehealth n Usual care 95% CI P
age (years) 12 64.1±9.0 12 62.8±7.4 -5.7 to -8.2 0.71
Male/female 12 6/6 12 6/6 1.0
FeV1 % predicted
# 12 50.0 (33.3–61.5) 12 36.0 (26.0–53.5) 0.25
BMI (kg/m2) 12 25.3±4.2 12 28.2±4.6 -6.6 to -0.9 0.126
exercise capacity (6MWT, m) 11 409.5±111.6 7 313.0±79.4 -6.8 to -199.7 0.065
Dyspnea (MrC scale)# 10 3.0 (2.0–3.3) 11 4.0 (3.0–4.0) 0.032*
health status (CCQ) 11 2.0±1.0 11 2.7±0.8 -1.5 to -0.1 0.079
Fatigue (MFI)# 11 12.0 (10.0–16.0) 11 16.0 (11.0–20.0) 0.26
Quality of life (EQ-5D) 
Vas 
Index
 
11 
11
 
64.1±15.9 
0.75±0.09
 
11 
9
 
65.0±12.0 
0.69±0.14
 
-13.5 to -11.7 
-0.05 to -0.17
 
0.88 
0.28
subjective activity (BPaQ) 10 7.1±1.4 10 6.2±1.3 -0.34 to 2.25 0.139
smokers/nonsmokers 11 4/7 12 4/8 1.0
employed/unemployed 12 5/7 11 2/9 0.371
Notes: Data shown as mean ± standard deviation with confidence interval (CI) except stated otherwise. *P,0.05; #nonparametric test, showing the median and interquartile 
range.
Abbreviations: 6MWT, 6-minute walking test; BMI, body mass index (in kg/m2); BPaQ, Baecke Physical activity Questionnaire; CCQ, clinical COPD questionnaire; COPD, 
chronic obstructive pulmonary disease; eQ-5D, euroQol; FeV1, forced expiratory volume in 1 second; m, meters; MFI, Multidimensional Fatigue Inventory (general fatigue 
scale); MrC, Medical research Council; Vas , Visual analogue scale.
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Figure 3 Median number of days (with interquartile range [IQr]) that the web portal was visited.
Note: Dotted line, patients that completed the intervention (n=10).
Table 2 Use of the intervention by the telehealth group (n=12)
n Treatment  
days
% of days  
visited
Diary Exercise Activity coach No  
commentsFill- 
outs
Checks Compl Perf Not  
perf
Compl Add  
ex
Visits  
port
Days’ use activity  
coach (monitor/ 
feedback)
1 92 67.4% 61 13 66.3% – – – 0 11 5 (5/0) 0
2 347 94.2% 321 54 92.5% 48 72 40.0% 123 29 30 (8/22) 2
3 336 65.5% 212 16 63.1% 33 128 20.5% 71 5 30 (7/23) 95
4 265 86.8% 227 61 85.7% – – – 0 21 28 (13/15) 0
5 316 94.9% 299 34 94.6% – 33 0 15 1 30 (9/21) 0
6 253 93.7% 234 154 92.5% – – – 21 27 27 (20/7) 0
7 259 79.5% 202 162 78.0% 10 31 24.4% 30 16 33 (21/12) 0
8 255 85.9% 204 28 80.0% 30 89 25.2% 283 19 38 (14/24) 0
9 250 95.6% 234 186 93.6% – – – 0 0 7 (7/0) 0
10 296 59.5% 174 133 58.8% – 27 0 0 15 39 (8/31) 0
11 144 47.2% 64 37 44.4% 6 22 21.4% 0 2 6 (6/0) 2
12 254 87.0% 218 180 85.8% – 23 0 0 4 26 (14/12) 0
Median 257 86.4% 215 58 82.8% 30 32 21.0% 8 13 29 (9/14) 0
sum 3,067 245 1,058 127 425 543 150 299 (132/167) 99
Abbreviations: Compl, compliance; Perf, performed; add ex, additional exercises; port, portal.
in COPD. For the telehealth group, the decision-support 
diary identified exacerbations, as described previously.19 The 
total telehealth group reported 33 exacerbations (median 
2.0, interquartile range 1.0–3.0) for which medication was 
required, of which one patient had eleven exacerbations 
according to the COPE II criteria. A number of these exacer-
bations occurred within 28 days of the previous exacerbation. 
Exacerbation data were not available for the control group. 
The telehealth group had in total four hospitalizations for 
COPD with a median duration of 5.5 days, while the con-
trol group had in total five hospitalizations for COPD with 
a median duration of 7.0 days. Table 4 shows the clinical 
measures obtained from the repeated measures. Data in Table 
4 are descriptive only, and present T0–T2.
Discussion
In this pilot study, a telehealth program was investigated 
within usual primary and secondary care to explore the 
potential for daily health care practice and to provide knowl-
edge for the implementation of larger-scale trials. The study 
showed that patients were satisfied with the received care, 
and that parts of the program were highly used during the 
9-month intervention period.
Use and satisfaction
The intervention was used on 86% of the treatment days, and 
this remained stable over the intervention period. This is a 
very high rate, as according to the World Health  Organization, 
adherence to long-term therapy in chronic diseases averages 
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Figure 4 number of patients who received exercise schemes from their physiotherapist (solid line), and the average number of schemes that were prescribed to these 
patients (dotted line) per month.
Table 3 number of hospitalizations, emergency room (er) visits, 
exacerbations, and length of stay for the telehealth and usual 
groups in the study period
Telehealth  
(n=12)
Usual care 
(n=12)
exacerbations/relapses, n 33 na
advice to start medication, n 35 na
hospitalizations for COPD, n 4 5
hospitalizations – other, n 4 2
length of stay, hospitalization for COPD 22 days 36 days
Median length of hospital stay for  
COPD, days
5.5 (4.8–6.3) 7.0 (6.0–7.0)
er visits for COPD, n 5 5
Note: Median length of stay shown with interquartile range.
Abbreviation: COPD, chronic obstructive pulmonary disease; er, emergency room; 
na, not applicable.
50%.26 The high usage of the intervention especially applied 
to the self-management module – including self-treatment 
of COPD exacerbations – probably because this module 
incorporated influential factors for good adherence:27 the 
patient was actively involved in the treatment process, in 
which they were educated in how to recognize their symp-
toms, but also in the importance of treatment. In addition, 
the self-management course was provided by their health 
care professional in an interactive real-life group setting with 
fellow patients, and the treatment regimen was simple and 
straightforward. Previous research on this self-management 
module showed it to be a successful aspect in the treatment 
of COPD exacerbations, with an 85% completion rate 
(unpublished data19), comparable to our study. In that study, 
patients were asked to return their completed paper diary 
by prepaid mail to the research office at the end of each 
month, and in the case of incorrect completion the patient 
was contacted by phone. To increase adherence to filling in 
our online diary even further, an option could be to apply 
the diary to a smartphone, where  the patient automatically 
receives a message to fill in the diary.
In contrast to the self-management module, the use of 
the exercise module and the activity coach was critically low. 
These modules showed 1) low use by the physiotherapists, 
and 2) low adherence of the patients. From the experience 
gained in this study, several reasons can be given.  Regarding 
the low use by the physiotherapists, one reason is that the 
physiotherapists did not regularly prescribe exercise schemes 
to the patients or incorporate the activity coach in the 
treatment program. Professionals are important in helping 
patients understand the nature of the disease and potential 
benefits of treatment and encouraging the development of 
self-management skills.27 As such, their attitude toward 
telehealth treatment can greatly influence the perception 
and adherence of the patients. In the literature, a reported 
problem regarding the use of telehealth by professionals is 
distrust in the technology due to problems with and reliability 
of the measurements.28,29 Another issue is that only a few 
patients of the health care professionals involved took part 
in the telehealth study, and thereby telehealth was not a part 
of their regular routine. Full-scale implementation in health 
care is needed in the future in which use and acceptance of 
all the users, including the health care professionals, should 
be investigated.
With regard to the low adherence to the exercise module 
by the patients, a reason could be that the technology was not 
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Table 4 Clinical changes obtained from repeated measures, with standard error of the mean
 Telehealth Usual care
T0 T1 T2 T0 T1 T2
exercise capacity (6MWT, m) 409.5 (29.5) na 412 (38.7) 300.1 (33.6) na 312.4 (44.0)
health status (CCQ) 2.0 (0.26) 1.9 (0.17) 1.8 (0.24) 2.7 (0.27) 2.3 (0.21) 2.3 (0.26)
Fatigue (MFI)   
 general fatigue 12.3 (1.4) 11.0 (1.1) 10.4 (1.3) 15.0 (1.4) 13.6 (1.3) 13.8 (1.5)
 Physical fatigue 12.2 (3.2) 11.9 (3.2) 11.0 (3.3) 16.5 (3.2) 14.4 (3.2) 14.4 (3.3)
 reduced activity 8.3 (1.2) 9.3 (0.9) 8.2 (1.2) 12.5 (1.3) 11.7 (1.1) 10.5 (1.3)
 reduced motivation 9.3 (1.1) 7.4 (0.9) 7.5 (1.2) 9.4 (1.2) 8.2 (1.0) 8.8 (1.3)
 Mental fatigue 8.5 (1.1) 9.9 (1.4) 6.6 (0.9) 7.0 (1.2) 8.0 (1.7) 7.3 (1.1)
Quality of life (eQ-5D)    
 Vas 64.7 (4.4) 73.1 (4.0) 72.3 (3.1) 65.0 (4.5) 69.3 (4.9) 62.4 (3.5)
 Index 0.76 (0.03) 0.81 (0.03) 0.78 (0.08) 0.70 (0.04) 0.72 (0.03) 0.61 (0.09)
subjective activity (BPaQ) 7.1 (0.4) 6.5 (0.4) 7.2 (0.4) 6.1 (0.4) 6.7 (0.4) 6.2 (0.4)
Objective activity (IMa;  
counts per minute)
536.3 (42.6) 556.7 (43.4) 511.0 (44.1) 360.5 (44.7) 381 (45.1) 335.2 (46.3)
Abbreviations: 6MWT, 6-minute walking test; BPaQ, Baecke Physical activity Questionnaire; CCQ, clinical COPD questionnaire; COPD, chronic obstructive pulmonary 
disease; eQ-5D, euroQol; IMa, integrated modulus of body acceleration; m, meters; MFI, Multidimensional Fatigue Inventory (general fatigue scale); na, not applicable; 
T0, inclusion; T1, 1 month; T2, 3 months; Vas, visual analogue scale.
sufficiently motivating or stimulating for doing exercises at 
home. The exercises were already familiar for the patients, 
as these are also used in regular care, and the schemes do 
not change very much over time. Providing these exercises 
online via a web portal might thus not have triggered patients 
enough to exercise. An alternative could be to incorporate 
motivational strategies, eg, by the use of gaming technologies, 
which can have a positive effect on motivation.30 
Patients were satisfied with the received care of the 
telehealth program. Internet-based therapy in other patient 
groups scored remarkably lower (eg, 20.6±4.8 in online 
psychotherapy31 to 24.5±4.832 and 22.8±4.631 for online 
cognitive behavioral therapy). The slightly lower satisfac-
tion scores for the telehealth group compared to the usual-
care group might be attributable to the frustrations some 
patients experienced with the activity coach. For example, 
some patients found it frustrating that it did not properly 
assess cycling, a very common activity in the Netherlands. 
This also has been reported earlier: Koff et al found low 
satisfaction scores for their activity sensor due to unreli-
able detection of slow walking, but high satisfaction for 
the telehealth program.33 Besides, interviews with patients 
after finishing the program showed that it is very impor-
tant to manage the expectations of the patient regarding 
such a new intervention and how (often) this web portal is 
used by the health care professionals, eg, how often will 
the professional look into the data on the web portal and 
when will the professional take action? When the patients’ 
expectations are in line with the received care, satisfaction 
is expected to increase too.
Implications
This pilot study provides important information for the 
implementation of a full study in daily care, ie, in terms 
of recruitment, randomization, follow-up assessment, and 
treatment. In this pilot, recruitment of patients was difficult, 
mainly because of the strict inclusion and exclusion criteria 
with a focus on patients with regular exacerbations, as well 
as the need of a computer with Internet access at home. In 
this age-group, the majority of people are not familiar with 
using the Internet, and as such worries about the use of the 
technology beforehand might have put the patients off and 
made recruitment more difficult.34
The study showed a high attrition rate. The strict criteria 
in relation to exacerbations/hospitalizations meant that the 
participants in general had a poor and unstable health status, 
especially in the control group, who had significantly worse 
dyspnea levels. A review by Beauchamp et al35 addressed 
this issue in supervised exercise programs after rehabilita-
tion, where acute exacerbations and disease progression 
contributed to the high dropout rate, which was also shown 
in our study. However, we do assume that the poor clinical 
characteristics of our control group were an exception. In a 
previous large study with exactly the same criteria,19 both 
the intervention and control groups showed comparable lung 
function and even better dyspnea levels than the telehealth 
group of our study. For future studies, the baseline charac-
teristics of participants lost to follow-up and those included 
in the analysis should be reported separately to help indicate 
possible attrition bias.36 Another option would be to also 
include patients with less frequent exacerbations. In this 
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group, the intervention would also be very suitable, and 
patients could be taught to self-manage their exacerbations 
in an earlier stage of their disease.
The losses to follow-up, together with the temporary 
unavailability of one physiotherapy practice, were also a rea-
son not all measurements were assessed. This made us unable 
to report the number of exacerbations in the control group, 
who had to fill in paper diaries for monitoring symptom lev-
els. Alternatively, in future we could monitor symptom levels 
on a smartphone, where the patient automatically receives a 
message to fill in the diary.
In relation to the treatment, our study showed low adher-
ence to the exercise and activity-coach modules. It is however 
very important to increase the use of these modules, since 
a higher usage of the activity coach has been shown to be 
significantly associated with an improvement in activity 
levels.22 Adherence might be increased by integrating these 
modules in a self-management program targeting both (post-)
exacerbation strategies and activity behavior.37 In this way, 
the intervention would also target exercise self-efficacy and 
expected benefits from regular exercise, which are predictors 
of exercise adherence.27 In this program, the activity coach 
can support both patients and professionals by providing 
insight in daily activity behavior and providing tools for 
changing activity behavior in daily life.
With all this taken into account, in a larger-scale study, 
a broader group of patients could be recruited. We expect 
that when the majority of the patients in the care centers 
participate in the intervention program, to make it feel like 
standard care for the professionals, this would increase the 
use of the program of both patients and professionals. In 
relation to treatment, the exercise and activity-coach modules 
should also be incorporated in a self-management program to 
increase adherence, and in which the management of patient 
expectations is addressed. Besides, miniaturized sensors and 
gamification strategies could further improve satisfaction 
and increase motivation to use these modules. This future 
research should be directed toward effectiveness as well as 
costs versus benefits of this integrated telehealth program.
Conclusion
In conclusion, this was the first study to apply an integrated 
telehealth intervention as blended care in patients with 
COPD that consisted of a real-time ambulant activity coach, 
a web portal for self-treatment of exacerbations in COPD, 
an online exercise program, and teleconsultation. The tele-
health program with decision support showed good satisfac-
tion, and parts of the intervention were highly used. Health 
care providers seem to play an important role in patients’ 
adherence to telehealth in usual care. Future research should 
focus on full-scale implementation in daily care. We would 
recommend 1) integrating all the modules in a standardized 
self-management program, in which management of patient 
expectations is addressed, and 2) investigating technological 
advances, like gaming, to increase adherence.
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